Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
JAMA Neurology
|
October 9, 2023
Amyloid Positron Emission Tomography and Subsequent Health Care Use Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
Gil D Rabinovici, Maria C Carrillo, Charles Apgar, et al.
JAMA Neurology
|
October 3, 2022
Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort Study
Consuelo H Wilkins, Charles C Windon, Peggye Dilworth-Anderson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Charles C Windon, Constantine Gatsonis, Justin Romanoff, et al.
JAMA Oncology
|
October 16, 2025
Radiotherapy With a 12-Gene Expression Assay for Ductal Carcinoma In Situ: A Randomized Clinical Trial
Seema A Khan, Justin Romanoff, Constantine Gatsonis, et al.
Future Oncology (London, England)
|
October 6, 2025
EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial)
Maeve A Hennessy, Constantine Gatsonis, Heather Jacene, et al.
JAMA Network Open
|
July 3, 2025
Quality of Life Among Patients With Ductal Carcinoma In Situ
Victoria J Dunsmore, Bradley S Snyder, Ilana F Gareen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 29, 2025
Amyloid PET and clinical management in a diverse, cognitively impaired population: The New IDEAS Study
Charles C Windon, Constantine Gatsonis, Maria C Carrillo, et al.
Radiology
|
September 5, 2018
Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial
Savannah C Partridge, Zheng Zhang, David C Newitt, et al.
JAMA Network Open
|
May 10, 2022
Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112)
Soudabeh Fazeli, Bradley S Snyder, Ilana F Gareen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2019
Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702)
Habib Rahbar, Zheng Zhang, Thomas L Chenevert, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
JAMA Neurology
|
October 9, 2023
Amyloid Positron Emission Tomography and Subsequent Health Care Use Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
Gil D Rabinovici, Maria C Carrillo, Charles Apgar, et al.
JAMA Neurology
|
October 3, 2022
Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort Study
Consuelo H Wilkins, Charles C Windon, Peggye Dilworth-Anderson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Charles C Windon, Constantine Gatsonis, Justin Romanoff, et al.
JAMA Oncology
|
October 16, 2025
Radiotherapy With a 12-Gene Expression Assay for Ductal Carcinoma In Situ: A Randomized Clinical Trial
Seema A Khan, Justin Romanoff, Constantine Gatsonis, et al.
Future Oncology (London, England)
|
October 6, 2025
EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial)
Maeve A Hennessy, Constantine Gatsonis, Heather Jacene, et al.
JAMA Network Open
|
July 3, 2025
Quality of Life Among Patients With Ductal Carcinoma In Situ
Victoria J Dunsmore, Bradley S Snyder, Ilana F Gareen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 29, 2025
Amyloid PET and clinical management in a diverse, cognitively impaired population: The New IDEAS Study
Charles C Windon, Constantine Gatsonis, Maria C Carrillo, et al.
Radiology
|
September 5, 2018
Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial
Savannah C Partridge, Zheng Zhang, David C Newitt, et al.
JAMA Network Open
|
May 10, 2022
Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112)
Soudabeh Fazeli, Bradley S Snyder, Ilana F Gareen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2019
Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702)
Habib Rahbar, Zheng Zhang, Thomas L Chenevert, et al.
Page
of 4